Anteilseigner
Farallon Capital Management LLC (9,84 %) RTW Investments LP (9,12 %) BlackRock Fund Advisors (7,21 %) The Vanguard Group, Inc. (5,20 %) SSgA Funds Management, Inc. (4,68 %) Point72 Asset Management LP (4,48 %) Johnson & Johnson Innovation - JJDC, Inc. (4,20 %) Bain Capital Life Sciences LP (4,06 %) Kynam Capital Management LP (3,44 %) Adage Capital Management LP (2,22 %) Jefferies Investment Advisers LLC (2,18 %) Geode Capital Management LLC (2,14 %) Morgan Stanley & Co. LLC (1,97 %) BlackRock Advisors LLC (1,67 %) DWS Investment GmbH (1,52 %) Dimensional Fund Advisors LP (1,40 %) T. Rowe Price Associates, Inc. (Investment Management) (1,36 %) 683 Capital Management LLC (1,23 %)
Kontakt
Protagonist Therapeutics Inc.